Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP is essentially a “GP of IP” – a true full-service IP firm with experts in every area of intellectual property and every technology. A comprehensive approach to clients’ IP needs and Finnegan’s mega-boutique size underpin the firm’s year-to-year, decade-to-decade pre-eminence in IP litigation across all industries and tribunals. From offices in the United States, Asia and Europe, Finnegan continues to be one of the world’s largest firms focusing on intellectual property, practising all aspects of patent, trademark, copyright and trade secret law and representing clients on IP issues relating to US and European patent and trademark law, international trade, portfolio management, the Internet, cybersecurity, e-commerce, government contracts, antitrust and unfair competition.

Finnegan offers full-service IP legal experience and technical expertise in virtually every industry and technology, including biotechnology, pharmaceuticals, biologics and biosimilars, chemicals, electronic devices and components, computers and software, financial services and business systems, AI and machine learning, digital health, nanotechnology, automotives, aerospace and aviation, industrial manufacturing, consumer products, media, food and beverage, medical devices, clean energy and renewables, robotics, sports and fitness, textiles and three-dimensional printing.

With the firm’s practice centred on intellectual property, it can create economies of scale and focus all resources on providing the best tools, practices and procedures for clients’ IP matters. More than 300 of Finnegan’s legal professionals hold degrees in scientific disciplines (over 60 hold PhDs), more than 200 are registered to practise before the USPTO and nearly 40 are former USPTO patent examiners. With more than 50 years’ IP experience, Finnegan handles hundreds of litigation cases across the spectrum of IP-related venues, including district courts, the US International Trade Commission (ITC), the USPTO’s PTAB, the Federal Circuit and the US Supreme Court. Finnegan was one of the first firms to file a petition and subsequently argue a post-grant review of a covered business method case following the implementation of the America Invents Act. Since then, it has been one of the busiest law firms representing petitioners and patent owners in post-grant review proceedings, with more than 90 covered business method reviews, more than a dozen post-grant reviews (few of which have been filed) and more than 700 inter partes review proceedings. The firm files approximately 2,500 US and 1,000 foreign patent applications annually.

Surveys conducted by legal and business publications consistently rank Finnegan as one of the leading IP law practices in the world. The firm is consistently ranked in the United States for contentious and prosecution trademark and patent work by publications including Managing Intellectual Property and Legal 500, which has ranked Finnegan as a top-tier firm in nearly every significant IP category since 2009. The publications cite the firm’s winning record, technical expertise and deep bench of talent in all aspects of IP litigation, including trials, appeals and proceedings at the USPTO and ITC investigations.

Representative engagements

  • Obtained a verdict of non-infringement for FedEx; the jury found that FedEx did not infringe Intellectual Venture’s four shipping and tracking patents and that three of the asserted patents were invalid. Intellectual Ventures had sought nearly $100 million in damages.
  • Filed a wave of 30 litigations against 20 different defendants seeking US Food and Drug Administration (FDA) approval to market generic versions of Kaken’s antifungal drug product, Jublia®.
  • Achieved affirmance of a willful infringement district court judgment and an approximately $61 million damages award for PPC Broadband regarding its coaxial cable connector technology.
  • Provided design patent application preparation, prosecution and counselling to Google with a focus on innovative graphical user interfaces and icons.
  • Represented Toyota in an ITC investigation and concurrent PTAB proceedings; led the joint defence group in discovery and strategic efforts, resulting in favourable decisions at the ITC and PTAB.
  • Provided ongoing strategic worldwide IP counselling to Vertex with a focus on its FDA-approved cystic fibrosis products, including Kalydeco®, Orkambi® and Symdeko®, as well as several preclinical compounds for its growing patent portfolios protecting these approved and future products for the treatment of cystic fibrosis.

Contact details

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
901 New York Avenue North West
Washington DC 20001-4413
United States

Professional contacts

Other offices

  • Atlanta
  • Boston
  • London
  • Palo Alto
  • Reston
  • Seoul
  • Shanghai
  • Taipei
  • Tokyo
  • Washington

Sample client list

  • AstraZeneca
  • Eli Lilly
  • FedEx
  • FIS
  • Google
  • LG
  • Nestlé
  • Otsuka
  • Philips
  • Sony
  • Toshiba
  • Toyota

Other recommended individuals at this firm